Cumberland Pharmaceuticals CPIX Balance Sheet (2010-2026)

NASDAQ CPIX
$7.65 -0.07 (-0.91%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Cumberland Pharmaceuticals Quarterly Balance Sheet

Periods 65 quarters
Latest Jun 2026

Cumberland Pharmaceuticals reported total assets of $62.88M and total liabilities of $45.44M for the quarter ended Jun 2026, down 7.4% year over year. This balance sheet covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
25.84M27.04M17.27M18.22M19.54M19.76M16.39M18.25M18.51M18.32M18.55M17.34M17.46M17.96M15.11M16.09M15.20M11.44M11.01M3.86M
Short-term InvestmentsInvestments (Current)
Cash & Current Investments
25.84M27.04M17.27M18.22M19.54M19.76M16.39M18.25M18.51M18.32M18.55M17.34M17.46M17.96M15.11M16.09M15.20M11.44M11.01M3.86M
Receivables - NetNet Receivables
9.85M6.88M14.64M13.28M15.23M13.16M14.53M12.22M12.62M9.76M10.65M11.62M11.31M11.70M10.49M10.32M10.43M16.94M14.26M13.42M
Receivables
9.85M6.88M14.64M13.28M15.23M13.16M14.53M12.22M12.62M9.76M10.65M11.62M11.31M11.70M10.49M10.32M10.43M16.94M14.26M13.42M
Raw Materials
Finished Goods
Inventory
10.26M8.43M9.88M9.42M10.65M9.86M10.18M10.93M8.67M4.61M4.33M4.30M4.51M4.00M4.10M3.22M2.93M0.03M5.45M0.03M
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets
3.34M3.08M3.03M2.68M2.32M1.95M2.79M2.18M1.58M1.38M0.65M2.07M0.68M
Current Assets
47.22M45.69M45.34M43.75M49.16M45.87M43.81M43.67M41.77M35.71M36.21M35.58M35.24M36.45M31.88M31.21M29.94M37.06M32.79M33.64M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
0.49M0.44M0.41M0.46M0.49M0.28M0.35M0.38M0.38M0.37M0.37M0.34M0.31M0.28M0.30M0.30M0.29M0.26M0.24M0.25M
Long-Term Investments
3.99M3.84M
Goodwill
0.88M0.88M1.93M1.93M1.93M0.91M0.91M0.91M0.91M0.91M0.91M0.91M0.91M0.91M0.91M0.91M0.91M0.91M0.91M
Intangibles
24.92M23.95M34.48M32.98M29.05M30.59M29.39M28.27M27.12M22.61M21.52M20.46M19.42M17.97M16.99M15.99M15.01M0.05M12.79M0.04M
Goodwill & Intangibles
25.80M24.84M36.41M34.91M30.98M31.50M30.30M29.18M28.04M23.52M22.44M21.37M20.33M18.89M17.90M16.90M15.92M0.97M13.71M0.04M
Long-Term Deferred Tax
Other Non-Current Assets
3.30M3.42M3.18M2.54M2.43M2.52M2.55M2.61M2.56M2.69M3.06M2.99M2.83M2.78M2.74M2.85M2.99M30.65M2.93M18.45M
Non-Current Assets
40.36M38.77M51.36M48.77M41.62M47.05M45.66M45.70M45.98M46.06M45.30M42.94M41.51M39.13M38.06M36.70M35.96M39.76M38.21M29.24M
Assets
87.57M84.46M96.70M92.52M90.78M92.93M89.47M89.38M87.75M81.78M81.51M78.52M76.75M75.58M69.94M67.91M65.90M76.82M71.00M62.88M
Liabilities
Current Liabilities
Accounts Payables
9.23M9.64M11.45M10.59M11.51M10.82M11.22M10.91M10.82M14.04M13.08M12.51M12.06M13.91M13.93M13.45M13.83M18.57M16.54M19.55M
Payables
9.23M9.64M11.45M10.59M11.51M10.82M11.22M10.91M10.82M14.04M13.08M12.51M12.06M13.91M13.93M13.45M13.83M18.57M16.54M19.55M
Accumulated Expenses
8.67M17.59M7.77M7.52M
Other Accumulated Expenses
7.62M8.67M12.34M13.15M13.57M17.59M14.33M15.73M16.18M13.60M12.99M11.87M12.65M12.25M11.22M10.14M10.08M2.86M12.98M2.24M
Short term Debt
5.99M5.10M
Total Current Liabilities
17.95M19.28M24.56M24.25M25.31M28.58M25.71M26.96M27.33M27.98M26.43M24.76M31.09M31.62M25.52M23.97M24.31M36.74M34.49M35.19M
Non-Current Liabilities
Non-Current Debt
15.00M15.00M20.00M19.00M17.70M16.20M16.07M13.15M12.92M12.78M16.08M16.09M10.10M10.18M5.24M5.24M5.24M5.24M5.24M
Minority Interest
-0.18M-0.21M-0.23M-0.26M-0.27M-0.29M-0.31M-0.32M-0.34M-0.34M-0.30M-0.32M-0.31M-0.31M-0.32M-0.31M-0.32M-0.34M-0.33M-0.33M
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
2.20M2.39M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
Operating Leases
0.23M0.09M0.02M4.59M4.55M5.48M5.39M5.30M5.20M5.10M5.00M4.94M4.83M4.71M4.60M4.47M4.34M4.21M
Other Non-Current Liabilities
7.75M7.49M11.32M10.06M9.28M7.59M7.09M6.95M6.46M6.45M6.61M6.54M6.09M6.30M6.01M6.30M5.95M3.63M5.62M3.98M
Total Non-Current Liabilities
33.18M34.37M44.58M43.25M42.61M49.37M46.33M45.58M45.64M46.06M47.71M45.95M46.19M46.74M35.59M33.93M33.83M48.32M44.07M41.46M
Total Liabilities
40.92M41.86M55.90M53.31M51.89M56.95M53.42M52.54M52.10M52.52M54.32M52.49M52.28M53.04M41.60M40.23M39.78M51.94M49.69M45.44M
Shareholder's Equity
Total Debt
15.00M15.00M20.00M19.00M17.70M16.20M16.07M13.15M12.92M12.78M16.08M16.09M16.09M15.28M5.24M5.24M5.24M5.24M5.24M
Common Equity
46.65M42.60M40.79M39.20M38.89M35.97M36.05M36.84M35.66M29.26M27.19M26.03M24.47M22.55M28.34M27.68M26.12M24.88M21.30M17.44M
Liabilities and Shareholders Equity
87.57M84.46M96.70M92.52M90.78M92.93M89.47M89.38M87.75M81.78M81.51M78.52M76.75M75.58M69.94M67.91M65.90M76.82M71.00M62.88M
Retained Earnings
-1.79M-5.64M-7.02M-8.36M-8.77M-11.21M-11.02M-10.14M-11.19M-17.49M-19.43M-20.52M-22.06M-23.97M-22.71M-23.45M-25.39M-26.80M-30.09M-34.37M

Cumberland Pharmaceuticals Balance Sheet API

Pull Cumberland Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CPIX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY